Enhanced delivery of octreotide to the brain via transnasal iontophoretic administration

Journal of Drug Targeting

Volumn 12, Issue 5, 2004, Pages 273-280

  Lerner, Eduard N ^a   Van Zanten, Elske H ^a   Stewart, Gregory R ^b  

^a Lerner Medical Technology Ltd   (Netherlands)

^b GENZYME CORPORATION   (United States)

Author keywords

Blood brain barrier; Electrotransport; Olfactory; Rabbit

Indexed keywords

OCTREOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD FLOW; BOLUS INJECTION; BRAIN REGION; CEREBELLUM; CEREBROSPINAL FLUID FLOW; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG INSTILLATION; DRUG TRANSPORT; ELECTRIC ACTIVITY; ELECTRIC FIELD; ELECTRODE; FEMALE; GRAVITY; INTERMETHOD COMPARISON; IONTOPHORESIS; MALE; NONHUMAN; NOSE CAVITY; OLFACTORY BULB; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; TISSUE INJURY;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; DRUG DELIVERY SYSTEMS; FEMALE; IONTOPHORESIS; MALE; OCTREOTIDE; RABBITS;

EID: 4644233768     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860400000938     Document Type: Article

References (38)

1. Bjorsen-Moller, F. and Fahrenkrug, J. (1971) "Nasal swell-bodies and cyclic changes in the air passage of the rat and rabbit nose", J. Anat. 110, 25-37.
2. Born, J., Lange, T., Kern, W., McGregor, G.P., Bickel, U. and Fehm, H.L. (2002) "Sniffing neuropeptides: a transnasal approach to the human brain", Nat. Neurosci. 5, 514-516.
3. Capsoni, S., Gianotta, S. and Cattaneo, A. (2002) "Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice", PNAS 99, 12432-12437.
4. Chen, X.Q., Fawcett, J.R., Rahman, YE., Ala, T.A. and Frey, W.H. (1998) "Delivery of nerve growth factor to the brain via the olfactory pathway", J. Alzheim. Res. 1, 35-44.
5. Dadiomova, V.G., Zastenker, F.S., Bakulina, K.I. and Kundel, L.M. (1969) "Nasal electrophoresis of dimedrol and calcium in pruritic dermatosis [Russian]", Vestn. Dermatol. Venerol. 43, 72-74.
6. Denecke, H., Czehak, N. and Pietrowsky, R. (2002) "Dose-response relationships of intranasal cholecystokinin and the P300 event-related brain potential", Pharmacol. Biochem. Behav. 73, 593-600.
7. Derad, I., Willeke, K., Pietrowsky, R., Born, J. and Fehm, H.L. (1998) "Intranasal angiotensin II directly influences central nervous regulation of blood pressure", Am. J. Hypertens. 11, 971-977.
8. Dermietzel, R. (1998) "Gap junction wiring: a 'new' principle in cell-to-cell communication in the nervous system", Brain Res. Rev. 26, 176-183.
9. Dufes, C., Olivier, J.C., Gaillard, F., Gaillard, A., Couet, W. and Muller, J.M. (2003) "Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration", Int. J. Pharm. 255, 87-97.
10. Frey, W.H. (2002) "Intranasal delivery. Bypassing the blood-brain barrier to deliver therapeutic agents to the brain and spinal cord", Drug Deliv. Tech. 2, 46-49.
11. Frey, W.H., Liu, J., Chen, X., Thorne, R.G., Fawcett, J.R., Ala, T.A. and Rahman, Y.-E. (1997) "Delivery of 125I-NGF to the brain via the olfactory route", Drug Deliv. 4, 87-92.
12. Gozes, I., Bardea, A., Reshef, A., Zamostiano, R., Zhukovsky, S., Rubinraut, S., Fridkin, M. and Brenneman, D.E. (1996) "Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide", PNAS 93, 427-432.
13. Gozes, I., Giladi, E., Pinhasov, A., Bardea, A. and Brenneman, D.E. (2000) "Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze", J. Pharm. Exp. Ther. 293, 1091-1098.
14. Illum, L. (2000) "Transport of drugs from the nasal cavity to the central nervous system", Eur. J. Pharm. Sci. 11, 1-18.
15. Illum, L. (2002) "Nasal drug delivery: new developments and strategies", Drug. Disc. Today 7, 1184-1189.
16. Khavinson, V.Kh., Morozov, V.G., Rybnikov, V.Iu. and Zakutskii, N.G. (1999) "Cortexin effectiveness in circulatory encephalopathy [Russian]", Klinich. Meditsina 77, 42-45.
17. Lerner, E.N. and Stewart, G.R. (2002) "Transnasal iontophoresis, a non-invasive brain drug delivery system that bypasses the blood-brain barrier", Clin. Auton. Res. 12, 303.
18. Liu, X.F., Fawcett, J.R., Thorne, R.G., DeFor, T.A. and Frey, W.H. (2001) "Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage", J. Neurol. Sci. 187, 91-97.
19. Marbach, P., Briner, U., Lemaire, M., Schweitzer, A. and Terasaki, T. (1993) "From somatostatin to Sandostatin: pharmacodynamics and pharmacokinetics", Digestion 1(54 suppl.), 9-13.
20. Mathison, S., Nagilla, R. and Kompella, U.B. (1998) "Nasal route for direct delivery of solutes to the central nervous system: fact or fiction", J. Drug Target. 5, 415-441.
21. Merkus, P., Guchelaar, H.J., Bosch, A. and Merkus, F.W.H.M. (2003) "Direct access of drugs to the human brain after intranasal drug administration?", Neurology 60, 1669-1671.
22. Minn, A., Leclerc, S., Heydel, J.M., Minn, A.L., Denizot, C., Cattarelli, M., Netter, P. and Gradinaru, D. (2002) "Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier", J. Drug Target. 10, 285-296.
23. Moran, D.T., Rowley, J.C., III, Jafek, B.W. and Lovell, M.A. (1982) "The fine structure of the olfactory mucosa in man", J. Neurocytol. 11, 721-746.
24. Pardridge, W.M. (1991) Peptide Drug Delivery to the Brain (Raven Press, New York), pp 1-357.
25. Pietrowsky, R., Claassen, L., Frercks, H., Fehm, H.L. and Born, J. (2001) "Time course of intranasally administered cholecystokinin-8 on central nervous effects", Neuropsychobiology 43, 254-259.
26. Pietrowsky, R., Struben, C., Molle, M., Fehm, H.L. and Born, J. (1996b) "Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans", Biol. Psychiatry 39, 332-340.
27. Pietrowsky, R., Thiemann, A., Kern, W., Fehm, H.L. and Born, J. (1996a) "A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin", Psychoneuroendocrinology 21, 559-572.
28. Rennels, M.L., Blaumanis, O.R. and Grady, P.A. (1990) "Rapid solute transport throughout the brain via paravascular fluid pathways", Adv. Neurol. 52, 431-439.
29. Rennels, M.L., Gregory, T.F., Blaumanis, O.R., Fujimoto, K. and Grady, P.A. (1985) "Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space", Brain Res. 326, 47-63.
30. Reubi, J.C. (1984) "Evidence for two somatostatin-14 receptor type in rat brain cortex", Neurosci. Lett. 49, 259-263.
31. Sakane, T., Akizuki, M., Taki, Y., Yamashita, S., Sezaki, H. and Nadai, T. (1995) "Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs", J. Pharm. Pharmacol. 47, 379-381.
32. Sakane, T., Akisuki, M., Yamashita, S., Nadai, T., Hashida, M. and Sezaki, H. (1991) "The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation of the lipophilicity of the drug", Chem. Pharm. Bull. 39, 2456-2458.
33. Sakane, T., Akizuki, M., Yamashita, S., Sezaki, H. and Nadai, T. (1994) "Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug", J. Pharm. Pharmacol. 46, 378-379.
34. Shipley, M.T. (1985) "Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium", Brain. Res. Bull. 15, 129-142.
35. Simpson, I., Rose, B. and Loewenstein, W.R. (1977) "Size limit of molecules permeating the junctional membrane channels", Science 195, 294-296.
36. Sokolova, T.S., Meshcheriakov, L.P., Bespal'ko, N.N., Sharpanova, I.K. and Nadtochii (1979) "Effectiveness of nasal electrophoresis of intal in the treatment of children with allergic rhinitis and rhinosinusitis [Russian]", Vestn. Otorinolaringol. 6, 57-60.
37. Washington, N., McGlashan, J.A., Jackson, S.J., Bush, D., Pitt, K.G., Rawlins, D.A. and Gill, D.A. (2000) "The effect of nasal patency on the clearance of radiolabeled saline in healthy volunteers", Pharm. Res. 17, 733-736.
38. Weir, C.D. (1967) "Intransasal ionization in the treatment of vasomotor nasal disorders", J. Laryngol Otol. 81, 1143-1150.